29 related articles for article (PubMed ID: 12077885)
21. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience.
Blenkinsopp A; Wilkie P; Wang M; Routledge PA
Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788
[TBL] [Abstract][Full Text] [Related]
22. Trouble at the FDA: can we fix the problems affecting you and your patients?
Henley E
J Fam Pract; 2006 Apr; 55(4):301-4. PubMed ID: 16608668
[No Abstract] [Full Text] [Related]
23. Clinical pharmacology and pharmacoepidemiology: future challenges for the European Community.
Royer RJ
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):449-52. PubMed ID: 1490777
[No Abstract] [Full Text] [Related]
24. [Not Available].
Hägerkvist R; Rönnemaa E; Dunder K; Gårdmark M; Ljung R
Lakartidningen; 2019 Apr; 116():. PubMed ID: 31192402
[No Abstract] [Full Text] [Related]
25. [Does collaboration inside the European Union improve Finnish drug safety?].
Palva E
Duodecim; 2000; 116(24):2810-1. PubMed ID: 12077885
[No Abstract] [Full Text] [Related]
26. [Experiences of the drug approval processes in the European Union].
Pasanen M; Toivonen M
Duodecim; 2000; 116(24):2817-22. PubMed ID: 12077887
[No Abstract] [Full Text] [Related]
27. Making the most of spontaneous adverse drug reaction reporting.
Waller PC
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):320-3. PubMed ID: 16611209
[TBL] [Abstract][Full Text] [Related]
28. Synthesising licensing data to assess drug safety.
McPherson K; Hemminki E
BMJ; 2004 Feb; 328(7438):518-20. PubMed ID: 14988197
[TBL] [Abstract][Full Text] [Related]
29. Drug regulation in the European Union.
Griffin JP
Adverse Drug React Toxicol Rev; 2000 Aug; 19(3):179-206. PubMed ID: 11059359
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
